Trends and dynamics of changes in aortic pulse wave velocity over one-year observation period in patients treated with peritoneal dialysis

International Journal of Artificial Organs

Volumn 27, Issue 10, 2004, Pages 904-906

  Stompór, Tomasz ^a   Rajzer, M ^a   Sulowicz W ^a   Dembinska Kiec A ^a   Janda, K ^a   Kawecka Jaszcz, K ^a   Wojcik K ^a   Tabor, B ^a   Zdzienicka, A ^a   Janusz Grzybowska, E ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

PATIENT TREATMENT; WAVE PROPAGATION;

OBSERVATION PERIOD; PERITONEAL DIALYSIS; PULSE-WAVE VELOCITY;

PATIENT MONITORING;

ACUTE PHASE PROTEIN; BIOCHEMICAL MARKER; C REACTIVE PROTEIN; CALCIUM; CYTOKINE; FIBRINOGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 6; LIPID; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PHOSPHATE; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; AORTA FLOW; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CHRONIC INFLAMMATION; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; FEMALE; HEMODYNAMICS; HUMAN; MALE; MORTALITY; PERITONEAL DIALYSIS; PRESSURE TRANSDUCER; PULSE WAVE; RISK FACTOR; AORTA; BLOOD; BLOOD FLOW VELOCITY; BLOOD PRESSURE; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PULSATILE FLOW;

AORTA; BLOOD FLOW VELOCITY; BLOOD PRESSURE; C-REACTIVE PROTEIN; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; LIPOPROTEIN(A); MALE; MIDDLE AGED; PERITONEAL DIALYSIS; PHOSPHATES; PULSATILE FLOW; TUMOR NECROSIS FACTOR-ALPHA;

EID: 16644378248     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139880402701012     Document Type: Article

References (20)

1. Sarnak M., Levey A. Cardiovascular disease and chronic renal disease: a new paradigm. Am J Kidney Dis 2000; 35 (suppl 1): S117-31.
2. Zimmermann J, Herrlinger S, Pruy A, Metzger T, Wanner C. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 1999; 55: 648-58.
3. Kalantar-Zadeh K, Kopple JD, Block G, Humphreys MH. A malnutrition-inflammation score is correlated with morbidity and mortality in maintenance hemodialysis patients. Am J Kidney Dis 2001; 38: 1251-63.
4. Arici M, Walls J. End-stage renal disease, atherosclerosis, and cardiovascular mortality: Is C-reactive protein the missing link? Kidney Int 2001; 59: 407-14.
5. Blacher J, Guerin AP, Pannier B, Marchais SJ, Safar ME, London GM. Impact of aortic stiffness on survival in end-stage renal disease. Circulation 1999; 99: 2434-9.
6. Blacher J, Safar ME, Guerin AP, Pannier B, Marchais SJ, London GM. Aortic pulse wave velocity index and mortality in end-stage renal disease. Kidney Int 2003; 63: 1852-60.
7. Guerin AP, Blacher J, Pannier B, Marchais SJ, Safar ME, London GM. Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure. Circulation 2001; 20: 987-92.
8. Laurent S, Boutouyrie P, Asmar R, Gautier I, Laloux B, Guize L, Ducimetiere P, Benetos A. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 2001; 37: 1236-41.
9. Blacher J, Demuth K, Guerin AP, Safar ME, Moatti N, London GM. Influence of biochemical alterations on arterial stiffness in patients with end-stage renal disease. Arterioscler Thromb Vasc Biol 1998; 18: 535-41.
10. Tycho Vuurmans JL, Boer WH, Bos WJ, Blankestijn PJ, Koomans HA. Contribution of volume overload and angiotensin II to the increased pulse wave velocity of hemodialysis patients. J Am Soc Nephrol 2002; 13: 177-83.
11. Mourad JJ, Pannier B, Blacher J, Rudnichi A, Benetos A, London GM, Safar ME. Creatinine clearance, pulse wave velocity, carotid compliance and essential hypertension. Kidney Int 2001; 59: 1834-41.
12. Kawaguchi Y, Kubo H, Yamamoto H, Nakayama M, Yokoyama K, Shigematsu T, Sakai O. Is atherosclerosis accelerated by CAPD? Perit Dial Int 1996; 16 (sluppl 1): S223-30.
13. Zoccali C, Benedetto FA, Maas R, Mallamaci F, Tripepi G, Malatino LS, Boger R; CREED Investigators. Asymmetric dimethylarginine, C-reactive protein, and carotid intimamedia thickness in end-stage renal disease. J Am Soc Nephrol 2002; 13: 490-6.
14. Bortolotto LA, Safar ME, Billaud E, Lacroix C, Asmar R, London GM, Blacher J. Plasma homocysteine, aortic stiffness, and renal function in hypertensive patients. Hypertension 1999; 34: 837-42.
15. London GM, Marchais SJ, Guerin AP, Metivier F, Adda H, Pannier B. Inflammation, arteriosclerosis, and cardiovascular therapy in hemodialysis patients. Kidney Int 2003; 84 (suppl): S88-93.
16. Guerin AP, London GM, Marchais SJ, Metivier F. Arterial stiffening and vascular calcifications in end-stage renal disease. Nephrol Dial Transplant 2000; 15: 1014-21.
17. Taquet A, Bonithon-Kopp C, Simon A, Levenson J, Scarabin Y, Malmejac A, Ducimetiere P, Guize L. Relations of cardiovascular risk factors to aortic pulse wave velocity in asymptomatic middle-aged women. Eur J Epidemiol 1993; 9: 298-306.
18. Ribeiro L, Gama G, Santos A, Asmar R, Martins L, Polonia J. Arterial distensibility in subjects with white-coat hypertension with and without diabetes or dyslipidaemia: Comparison with normotensives and sustained hypertensives. Blood Press Monit 2000; 5: 11-7.
19. Pannier BM, Cambillau MS, Vellaud V, Atger V, Moatti N, Safar ME. Abnormalities of lipid metabolism and arterial rigidity in young subjects with borderline hypertension. Clin Invest Med 1994; 17: 42-51.
20. Tanaka H, DeSouza CA. Seals DR. Absence of age-related increase in central arterial stiffness in physically active women. Arterioscler Thromb Vasc Biol 1998; 18: 127-32.